Advanced Search

 

Study ID Status Title Patient Level Data
113929 Completed BRF113929: An Open-Label, Two-Cohort, Multicentre Study of GSK2118436 as a Single Agent in Treatment Naïve and Previously Treated Subjects with BRAF Mutation-Positive Metastatic Melanoma to the Brain
113950 Completed A Single-Centre, Randomised, Open-label Study to Evaluate the Effects of Steady-State Verapamil, a Moderate P-Glycoprotein and CYP3A4 Inhibitor, on the Pharmacokinetics of GSK573719 and GSK573719 in Combination with GW642444 Study Listed on ClinicalStudyDataRequest.com
113954 Completed Antibody persistence and immune memory against the hepatitis B antigen in 11-12 year old children, previously vaccinated with DTPa-HBV-IPV/Hib vaccine in study 217744/031 Study Listed on ClinicalStudyDataRequest.com
113962 Completed Risk of hemorrhage in patients prescribed Arixtra compared to LMWH
113970 Completed An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment. Study Listed on ClinicalStudyDataRequest.com
113971 Completed An Open-Label Study to Evaluate the Effects of Ketoconazole and the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Repeat Doses of Pazopanib in Subjects with Solid Tumor Malignancies
113978 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine administered as a booster dose in 12-18 months old healthy children Study Listed on ClinicalStudyDataRequest.com
113979 Completed Economic Analyses Alongside the REDUCE Clinical Trial
113984 Completed Dutasteride in Enlarged Prostate economic assessment: A retrospective database pooled analysis of early 5-alpha reductase inhibitor use
113989 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and FF Inhalation Powder in Japanese Subjects with asthma Study Listed on ClinicalStudyDataRequest.com
114000 Completed A study to evaluate the safety and efficacy of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children aged 6 months to less than 10 years of age Study Listed on ClinicalStudyDataRequest.com
114009 Completed A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104 on the endotoxin induced inflammatory response in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
114010 Completed A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114011 Completed A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
114041 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
114043 Active, Not Recruiting Systematic Review and Meta-Analysis of the Impact of Alternative Treatments on Mortality Outcomes in Chronic Obstructive Pulmonary Disease (COPD)
114068 Completed A Single-centre, Randomised, Double-blind, Placebo-controlled, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers Study Listed on ClinicalStudyDataRequest.com
114070 Completed A single-blind, placebo-controlled, two part study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of GSK2018682 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114089 Completed A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114092 Completed A multicenter, open-label, dose ranging study to determine the pharmacokinetics and pharmacodynamics of mepolizumab administered intravenously or subcutaneously to adult asthmatic subjects with elevated blood eosinophil levels Study Listed on ClinicalStudyDataRequest.com
114101 Completed Post-marketing safety study to assess the risk of spontaneous abortions in women exposed to Cervarix in the United Kingdom
114130 Completed A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment Study Listed on ClinicalStudyDataRequest.com
114136 Completed A single dose, open label, nonrandomized, study to evaluate the pharmacokinetics and absolute bioavailability of GSK962040 given as an oral dose simultaneously with an intravenous microtracer dose of [14C]-GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114137 Completed An open label, randomized, up-titration study to assess the effect of urine sample handling procedures on the safety results of urine obtained from healthy subjects receiving repeat doses of ezogabine/retigabine. Study Listed on ClinicalStudyDataRequest.com
114155 Completed An open-label pilot study to evaluate the safety, tolerability,pharmacokinetics, exploratory efficacy and pharmacodynamicsof oral pazopanib administered for 28 days to neovascular age-relatedmacular degeneration patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.